Cristina Penaranda, Ph.D.

Affiliations: 
2005-2010 Biomedical Sciences University of California, San Francisco, San Francisco, CA 
Area:
Immunology
Google:
"Cristina Penaranda"

Parents

Sign in to add mentor
Jeffrey A. Bluestone grad student 2005-2010 UCSF (Cell Biology Tree)
 (Therapeutic interventions to modulate the anti-islet response in autoimmune diabetes.)
Deborah T. Hung post-doc 2012-2020 Harvard
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Penaranda C, Chumbler NM, Hung DT. (2021) Dual transcriptional analysis reveals adaptation of host and pathogen to intracellular survival of Pseudomonas aeruginosa associated with urinary tract infection. Plos Pathogens. 17: e1009534
Betin V, Penaranda C, Bandyopadhyay N, et al. (2019) Hybridization-based capture of pathogen mRNA enables paired host-pathogen transcriptional analysis. Scientific Reports. 9: 19244
Poulsen BE, Yang R, Clatworthy AE, et al. (2019) Defining the core essential genome of . Proceedings of the National Academy of Sciences of the United States of America
Penaranda C, Hung DT. (2019) Single-Cell RNA Sequencing to Understand Host-Pathogen Interactions. Acs Infectious Diseases
Parada-Kusz M, Penaranda C, Hagedorn EJ, et al. (2018) Generation of mouse-zebrafish hematopoietic tissue chimeric embryos for hematopoiesis and host-pathogen interaction studies. Disease Models & Mechanisms
Avraham R, Haseley N, Brown D, et al. (2015) Pathogen Cell-to-Cell Variability Drives Heterogeneity in Host Immune Responses. Cell. 162: 1309-21
Folias AE, Penaranda C, Su AL, et al. (2014) Aberrant innate immune activation following tissue injury impairs pancreatic regeneration. Plos One. 9: e102125
Wieland Brown LC, Penaranda C, Kashyap PC, et al. (2013) Production of α-galactosylceramide by a prominent member of the human gut microbiota. Plos Biology. 11: e1001610
Penaranda C, Kuswanto W, Hofmann J, et al. (2012) IL-7 receptor blockade reverses autoimmune diabetes by promoting inhibition of effector/memory T cells. Proceedings of the National Academy of Sciences of the United States of America. 109: 12668-73
Penaranda C, Tang Q, Bluestone JA. (2011) Anti-CD3 therapy promotes tolerance by selectively depleting pathogenic cells while preserving regulatory T cells. Journal of Immunology (Baltimore, Md. : 1950). 187: 2015-22
See more...